Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App
Success
Alert
Please select a Day.
Info

Bliss GVS Pharma Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

55/100
215.59
-2.39 (-1.10%)

As on 30 Mar, 2026 | 03:56

Open Trading A/c
Day Range
214.13
226.85
L H
52 Week Range
108.12
243.90
L H
Volume
1,853,918
*
i

* BSE Market Depth (30 Mar 2026)

BUY SELL
QTY PRICE PRICE QTY
20 215.00 216.80 50
600 213.70 217.00 25
152 212.00 218.90 100
100 211.00 221.60 25
410 210.00 221.80 50
0 Total Total 0
Bid / Ask
0.00 / 0.00
55/100
216.65
-2.45 (-1.12%)

As on 30 Mar, 2026 | 04:01

Open Trading A/c
Day Range
214.25
226.85
L H
52 Week Range
105.05
244.05
L H
Volume
101,822
*
i

* BSE Market Depth (30 Mar 2026)

BUY SELL
QTY PRICE PRICE QTY
20 215.00 216.80 50
600 213.70 217.00 25
152 212.00 218.90 100
100 211.00 221.60 25
410 210.00 221.80 50
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
71% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 215.20
          Previous Close 217.98
          Volume 1,853,918.00
          Value (Lacs) 3,996.86
            VWAP 220.06
          Beta
          Mkt Cap (Rs. Cr.) 2,281
          High 226.85
          Low 214.13
          UC Limit 261.57
          LC Limit 174.39
          52 Week High 243.90
          52 Week Low 108.12
          Face Value 1.00
          All Time High 243.90
          All Time Low 18.80
          20D Avg Volume 1,707,357
          20D Avg Delivery(%) 33.84
          Book Value Per Share 109.38
          Dividend Yield 0.23
          TTM EPS See historical trend 10.31 (+82.23% YoY)
          TTM PE See historical trend 20.91 (High PE)
          P/B See historical trend 1.98 (High P/B)
          Sector PE 39.21

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          55/100
          Average Financial Strength, Average Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 11.61% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoters decreased holding from 35.39% to 35.36% in Dec 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          9 out of 16 years Bliss GVS Pharma has given negative returns in March.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          March 20.62% (2015) 6.69% -43.56% (2021) -13.45% -4.64%

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Bliss GVS

          What's your call on Bliss GVS today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          05 Feb, 2026

          Arian Investment Ltd

          Qty 1400000 Price 180.1 % Traded 1.28
          05 Feb, 2026

          Mateus Ltd

          Qty 1400000 Price 180.1 % Traded 1.28
          20 Oct, 2025

          Arian Investment Ltd

          Qty 2600000 Price 150.6 % Traded 2.38
          20 Oct, 2025

          Mateus Ltd

          Qty 2600000 Price 150.6 % Traded 2.38

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          25 Mar, 2026

          Hrti Private Limited

          Qty 581292 Price 224.86 % Traded 0.55
          25 Mar, 2026

          Hrti Private Limited

          Qty 517506 Price 224.26 % Traded 0.49
          20 Mar, 2026

          Ratnabali Equity Private Limited

          Qty 717102 Price 212.11 % Traded 0.68
          20 Mar, 2026

          Ratnabali Equity Private Limited

          Qty 717000 Price 212.56 % Traded 0.68
          19 Mar, 2026

          Arian Investment Ltd

          Qty 1000000 Price 210.82 % Traded 0.96
          19 Mar, 2026

          Mateus Ltd

          Qty 933978 Price 210.81 % Traded 0.90
          24 Feb, 2026

          Mansukh Securities & Finance Limited

          Qty 620900 Price 216.22 % Traded 0.60
          24 Feb, 2026

          Mansukh Securities & Finance Limited

          Qty 620900 Price 220.81 % Traded 0.62

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          About the Company

          Bliss GVS Pharma Ltd.is engaged in the manufacture of a wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.The companys most unique product is Today Vaginal Contraceptive, a safe female contraceptive .The Prescription drugs of the company include Alaxin, Gvither, P-Alaxin, Gsunate and Lonart ,Rectol, Poroxicam, Parafen, Vomitin, Slipizem, AnomexProchloperazine, Imazole, Gvgyl, Terconazole, Vagid, Gvgyl - N, etc. and over the counter products are Today Regular, Today Economy, Today Premium.Maitri Vaginal Lubricant Pessary,etc.
          {"success":1,"data":{"address":{"address1":"102, Hyde Park,","address2":"Saki Vihar Road,,Andheri - East,","city":"Mumbai","state":"Maharashtra","pincode":"400072","telephone1":"022-42160000","telephone2":"","fax1":"022-28563930","fax2":"","email":"info@blissgvs.com","web":"http:\/\/www.blissgvs.com"},"management":[{"name":"Nandkumar K Chodankar","designation":"Chairman & Ind.Director"},{"name":"Gagan Harsh Sharma","designation":"Managing Director"},{"name":"Vibha Gagan Sharma","designation":"Whole Time Director"},{"name":"Shruti Vishal Rao","designation":"Whole Time Director"},{"name":"Santosh L Parab","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"506197","nseId":"BLISSGVS","series":"EQ","isinid":"INE416D01022"}}}
          • Registered Office

            • Address

              102, Hyde Park,,Saki Vihar Road,,Andheri - East,

            • City

              Mumbai

            • State

              Maharashtra

            • Pin Code

              400072

            • Tel. No.

              022-42160000

            • Fax No.

              022-28563930

            • Email

              info@blissgvs.com

            • Internet

              http://www.blissgvs.com

          • Registrars

          • Management

            • Nandkumar K Chodankar

              Chairman & Ind.Director

            • Gagan Harsh Sharma

              Managing Director

            • Vibha Gagan Sharma

              Whole Time Director

            • Shruti Vishal Rao

              Whole Time Director

            • Santosh L Parab

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              506197

            • NSE:

              BLISSGVS

            • Series

              EQ

            • ISIN

              INE416D01022

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347